Bio-Techne (NASDAQ:TECH) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Bio-Techne (NASDAQ:TECH – Get Rating) released its quarterly earnings results on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. The company had revenue of $294.15 million for the quarter, compared to analyst estimates of $298.55 million. Bio-Techne had a net margin of 24.15% […]